文献速递心胸血管麻醉

亚甲蓝对心脏术后微循环障碍的影响:前瞻性队列研究

Effects of methylene blue on microcirculatory alterations following cardiac surgery: A prospective cohort study.
PubMed 文献 · Eur J Anaesthesiol · 2022-01-01

本研究为前瞻性开放标签队列研究,纳入25例心脏术后难治性血管麻痹综合征成人患者,在基线和亚甲蓝1.5 mg kg-1静脉给药后1小时评估血流动力学及舌下微循环。结果显示尽管心脏指数和平均动脉压已正常化,微循环仍严重障碍;亚甲蓝可改善微血管灌注和反应性,部分恢复血流动力学一致性。

要点

  • 心脏术后难治性血管麻痹患者尽管CI和MAP正常化,仍存在严重微循环障碍。
  • 亚甲蓝1.5 mg kg-1可显著提高MFI、总血管密度、灌注血管密度及组织氧再饱和速率。
  • 毛细血管再充盈时间在亚甲蓝给药后无变化。

核心结论

  • 心脏术后难治性血管麻痹综合征患者存在微循环障碍,亚甲蓝可改善微血管灌注和反应性,部分恢复血流动力学一致性。

研究设计与样本

  • 前瞻性开放标签队列研究,在三级医院20张床ICU进行,纳入25例成人心脏术后难治性血管麻痹综合征患者。

主要发现

  • 基线时尽管CI为2.6 [2.0至3.8] l min-1 m-2、MAP为66 [55至76] mmHg,MFI仍小于2.6提示严重微循环障碍。
  • 亚甲蓝输注后MFI从2.0 [0.1至2.5]升至2.2 [0.2至2.8](P=0.008)。
  • 总血管密度从13.5 [8.3至18.5]升至14.9 [10.1至14.7] mm mm-2(P=0.02)。
  • 灌注血管密度从7.4 [0.1至11.5]升至9.1 [0至20.1] mm mm-2(P=0.02),但个体差异大。
  • 组织氧再饱和速率从0.5 [0.1至1.8]升至0.7 [0.1至2.7]% s-1(P=0.002),毛细血管再充盈时间无变化。

关键数值与推荐

  • 难治性血管麻痹综合征定义为需去甲肾上腺素大于0.5 μg kg-1 min-1维持MAP大于65 mmHg且CI大于2.0 l min-1 m-2。
  • 亚甲蓝剂量为1.5 mg kg-1静脉给药。
  • 微循环评估采用旁流暗场成像获取MFI、总血管密度、灌注血管密度和异质性指数,微血管反应性采用外周近红外光谱结合血管闭塞试验。

临床怎么用

  • 对于心脏术后难治性血管麻痹综合征患者,即使CI和MAP达标,仍应关注微循环状态。
  • 亚甲蓝可作为改善微循环灌注和反应性的 rescue 治疗选择,但需注意个体反应差异。

局限性

  • 本研究为开放标签、单中心、小样本队列研究,无对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Methylene blue is used as rescue therapy to treat catecholamine-refractory vasoplegic syndrome after cardiac surgery. However, its microcirculatory effects remain poorly documented. OBJECTIVE: We aimed to study microcirculatory abnormalities in refractory vasoplegic syndrome following cardiac surgery with cardiopulmonary bypass and assess the effects of methylene blue. DESIGN: A prospective open-label cohort study. SETTING: 20-Bed ICU of a tertiary care hospital. PATIENTS: 25 Adult patients receiving 1.5 mg kg-1 of methylene blue intravenously for refractory vasoplegic syndrome (defined as norepinephrine requirement more than 0.5 μg kg-1 min-1) to maintain mean arterial pressure (MAP) more than 65 mmHg and cardiac index (CI) more than 2.0 l min-1 m-2. MAIN OUTCOME MEASURES: Complete haemodynamic set of measurements at baseline and 1 h after the administration of methylene blue. Sublingual microcirculation was investigated by sidestream dark field imaging to obtain microvascular flow index (MFI), total vessel density, perfused vessel density and heterogeneity index. Microvascular reactivity was assessed by peripheral near-infrared (IR) spectroscopy combined with a vascular occlusion test. We also performed a standardised measurement of capillary refill time. RESULTS: Despite normalised CI (2.6 [2.0 to 3.8] l min-1 m-2) and MAP (66 [55 to 76] mmHg), patients with refractory vasoplegic syndrome showed severe microcirculatory alterations (MFI < 2.6). After methylene blue infusion, MFI significantly increased from 2.0 [0.1 to 2.5] to 2.2 [0.2 to 2.8] (P = 0.008), as did total vessel density from 13.5 [8.3 to 18.5] to 14.9 [10.1 to 14.7] mm mm-2 (P = 0.02) and perfused vessel density density from 7.4 [0.1 to 11.5] to 9.1 [0 to 20.1] mm mm-2 (P = 0.02), but with wide individual variation. Microvascular reactivity assessed by tissue oxygen resaturation speed also increased from 0.5 [0.1 to 1.8] to 0.7 [0.1 to 2.7]% s-1 (P = 0.002). Capillary refill time remained unchanged throughout the study. CONCLUSION: In refractory vasoplegic syndrome following cardiac surgery, we found microcirculatory alterations despite normalised CI and MAP. The administration of methylene blue could improve microvascular perfusion and reactivity, and partially restore the loss of haemodynamic coherence. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT04250389.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Maurin C, Portran P, Schweizer R, et al. Effects of methylene blue on microcirculatory alterations following cardiac surgery: A prospective cohort study. Eur J Anaesthesiol. 2022. PMID: 34610607. doi:10.1097/EJA.0000000000001611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。